Insulet Corporation (PODD) financial statements (2022 and earlier)

Company profile

Business Address 100 NAGOG PARK
ACTON, MA 01720
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 857872850948897844
Cash and cash equivalents 857855821907838779
Short-term investments 11830405965
Restricted cash and investments2      
Receivables16113011811795101100
Inventory, net of allowances, customer advances and progress billings303259198170154125104
Inventory303259198170154125104
Capitalized contract cost13131212111010
Other undisclosed current assets851485243402827
Total current assets:1,3301,3071,2531,1921,2491,1601,086
Noncurrent Assets
Property, plant and equipment537515506498479449423
Long-term investments and receivables     124
Long-term investments     124
Intangible assets, net (including goodwill)76777370695051
Goodwill40404040404040
Intangible assets, net (excluding goodwill)37373330291011
Capitalized contract cost, net 242423 2120
Other noncurrent assets106   77  
Other undisclosed noncurrent assets 756858 3024
Total noncurrent assets:719692671648624550541
TOTAL ASSETS:2,0491,9991,9241,8401,8731,7111,627
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:20420019217013817599
Accounts payable38584959 57 
Accrued liabilities166142143111 118 
Employee-related liabilities    53 33
Other undisclosed accounts payable and accrued liabilities    85 66
Deferred revenue    5  
Debt2529211616  
Other undisclosed current liabilities    49 36
Total current liabilities:229229213186208175134
Noncurrent Liabilities
Long-term debt and lease obligation1,2491,2571,2351,0521,044922910
Long-term debt, excluding current maturities1,2491,2571,2351,0521,044922910
Liabilities, other than long-term debt15151618181919
Other liabilities15151618181919
Total noncurrent liabilities:1,2641,2721,2511,0691,062940929
Total liabilities:1,4931,5011,4651,2551,2691,1161,063
Stockholders' equity
Stockholders' equity attributable to parent556498459585604595563
Common stock0000000
Additional paid in capital1,2081,1801,1501,2481,2641,2451,228
Accumulated other comprehensive income (loss)(2)(3)136(1)(4)
Accumulated deficit(650)(679)(691)(666)(666)(649)(661)
Total stockholders' equity:556498459585604595563
TOTAL LIABILITIES AND EQUITY:2,0491,9991,9241,8401,8731,7111,627

Income statement (P&L) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues308276263252246234226
Cost of revenue
(Cost of Goods and Services Sold)
(95)(87)(81)(85)(85)(82)(84)
Gross profit:213189183168161152143
Operating expenses(164)(155)(156)(151)(168)(128)(115)
Operating income (loss):50342616(7)2428
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(0)(1)2(3)111
Interest and debt expense(16)(18)(57)(14)(13)(12)(12)
Other undisclosed income from continuing operations before equity method investments, income taxes  00011
Income (loss) from continuing operations before equity method investments, income taxes:3315(28)0(19)1317
Other undisclosed income from continuing operations before income taxes 0     
Income (loss) from continuing operations before income taxes:3315(28)0(19)1317
Income tax expense (benefit)(4)(3)3(0)1(2)(3)
Net income (loss) available to common stockholders, diluted:2913(25) (17)1214

Comprehensive Income ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net income (loss):2913(25) (17)1214
Comprehensive income (loss):2913(25) (17)1214
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1(4)(3)(2)630
Comprehensive income (loss), net of tax, attributable to parent:309(28)(2)(11)1515

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: